Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 22, 2025 04:33 ET | Source: Research and Markets

Antimicrobial Resistance Diagnostics Market Outlook 2024-2030 | WGS Driving Molecular Tests, Multiplex POCT, and Antimicrobial Stewardship Through Private-Public Partnerships

Dublin, April 22, 2025 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostics Market, Global, 2024-2030" report has been added to ResearchAndMarkets.com's offering.This report examines the...
April 09, 2025 07:07 ET | Source: Research and Markets

Peptide Antibiotics Industry Report 2025 | Antibiotic Resistance Crisis Fuels Demand as Market Surges Toward USD 8.4 Billion

Dublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "Peptide Antibiotics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...
December 31, 2024 05:58 ET | Source: Research and Markets

Antimicrobial Resistance Diagnostic Markets, Strategies and Trends Report 2024 with Executive Guides and 5 Year Forecasts

Dublin, Dec. 31, 2024 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides and Customization 2023 to 2027"...
December 26, 2024 04:45 ET | Source: Research and Markets

Antibiotic Resistance Therapeutics Market Research Report 2025-2029 - Search for Alternatives to Antibiotics Creates New Global Goldrush

Dublin, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Therapeutics Market 2025-2029 - Insights by Pathogen and Therapy Type, with Situation Analysis, Executive, and Investor Guides"...
October 15, 2024 10:31 ET | Source: Research and Markets

Antibiotic Resistance Research Report 2024: 6 Key Large Opportunities in this Space and Developed Market Forecasts with Profiles of 100+ Biotechnology Companies

Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...
October 14, 2024 07:31 ET | Source: Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals Announces Presentation of Several New Studies of NUZYRA® (omadacycline) Across a Range of Serious Infections at IDWeek 2024

Paratek Pharmaceuticals Announces Presentation of Several New Studies of NUZYRA® (omadacycline) Across a Range of Serious Infections at IDWeek 2024
September 26, 2024 04:03 ET | Source: inbiome

Inbiome Receives FDA Breakthrough Device Designation for Revolutionary Molecular Culture ID Technology, Transforming Bacterial Diagnostics

www.inbiome.com More precise diagnostics lead to quicker, more accurate patient treatment, saving lives and improving patient outcomesUS market introduction foreseen early 2026 ...
July 31, 2024 07:30 ET | Source: Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline) Demonstrating No Change in In Vitro Potency Against Indicated Pathogens

Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline)
July 22, 2024 13:47 ET | Source: SNS Insider pvt ltd

Antimicrobial Resistance Surveillance Market Size to Hit US$ 9.50 Billion by 2032, Rising Prevalence of Drug-Resistant Infections Drives Growth | Research by SNS Insider

Pune, July 22, 2024 (GLOBE NEWSWIRE) -- Antimicrobial Resistance Surveillance Market Size Analysis: “According to SNS Insider Research, The Antimicrobial Resistance Surveillance Market is...
July 22, 2024 09:15 ET | Source: Research and Markets

$230+ Bn Anti-Infectives Markets - Global Strategic Business Report to 2030: Telemedicine and Digital Health Platforms Drives Adoption, Rising Prevalence of Drug-Resistant Infections Spurs Innovation

Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Anti-Infectives - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Anti-Infectives...

Next Page keyboard_arrow_right